MYCBP elisa kit product blogThe Goat MYCBP mycbp (Catalog #MBS7243487) is an ELISA Kit and is intended for research purposes only. The product is available for immediate purchase. The MBS7243487 ELISA Kit recognizes Goat (General) MYCBP.
The MYCBP mycbp product has the following accession number(s) (GI #57242777) (NCBI Accession #NP_036465.2). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Samples: Serum, plasma, Cell Culture Supernatants, body fluid and tissue homogenate. Goat C-Myc-binding protein (MYCBP) ELISA Kit or ELISA (enzyme-linked immunosorbant assays) Kits in general, are a valuable research tool for a myriad of applications in a range of scientific settings. Currently, three major types of ELISA formats are used by researchers: sandwich, competitive and indirect. Most commercially available ELISA Kits are sandwich or competitive. Commercially available ELISA Kits contain wells that have been pre-coated with the capture antibody. Please refer to the product manual for the ELISA format of your specific kit. Blood, Bone, Bone Marrow, Embryonic Tissue, Liver, Lymph Node, Prostate, Stomach, Testis, Vascular tissues are correlated with this protein. Adenocarcinoma, Breast Neoplasms, Cell Transformation, Neoplastic, Hyperplasia, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Experimental, Prostatic Diseases, Urinary Bladder Neoplasms are some of the diseases may be linked to Goat C-Myc-binding protein (MYCBP) ELISA Kit. The following patways have been known to be associated with this gene. MYCBP also interacts with the following gene(s): AKAP1, ARFGEF1, C3orf15, MYC, MYCBPAP.